Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO and Moore RE: '584-- "in context"

Jul 05, 2007 10:19AM

Jul 05, 2007 11:06AM

Jul 05, 2007 11:24AM

Jul 05, 2007 12:33PM

Jul 05, 2007 12:34PM

Jul 05, 2007 01:03PM

Jul 05, 2007 05:05PM

Question.

In the reexam, does the inventers get to fine tune any questionable issues? Would Moore et al get to explain and mybe even add language to the claim at issue to clarify ? 

Is the burden of the patent owner , to have done a "perfect" job in the orignal text when issued? If you don't explain or screw up a sentence or phrase at the time, well enough are you ship out of luck? Hindsight is 20/20 for sure, however what about "in context"

As Nathan_Hale just stated , "After all , isn't it suppose to be for multiple instruction fetch?" ..........Vey good question..........that is the context of the issue, so a slight wording error are words left out at the time.................Do we get to clarify and adjust, after all the sprit of the patent and the context is correct. Is that part of the reexam process?

Would be nice.

Ron

Jul 06, 2007 06:20AM

Jul 06, 2007 06:30AM

Jul 06, 2007 06:53AM

Jul 06, 2007 07:52AM

Jul 06, 2007 08:10AM

Jul 06, 2007 08:11AM

Jul 06, 2007 08:13AM

Jul 06, 2007 08:13AM

Jul 06, 2007 08:20AM

Jul 06, 2007 08:23AM

Jul 06, 2007 08:51AM

Jul 06, 2007 10:59AM

Jul 06, 2007 01:23PM

Jul 06, 2007 09:00PM

Jul 07, 2007 08:17AM
Share
New Message
Please login to post a reply